Ways2Well vs Willow
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Ways2Well
Best for patients wanting required-labs structure rather than questionnaire-only intakeStarting at $219/mo
Willow
Best for mainstream telehealth GLP-1 accessStarting at $299/mo
Side-by-Side Comparison
| Feature | Ways2Well | Willow |
|---|---|---|
| Overall Score | 7.1/10 | ✓7.2/10 |
| Starting Price | ✓$219/mo | $299/mo |
| Customer Rating | — | — |
| Features | ✓5 features | 3 features |
| States Available | 50 | 50 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Ways2Well
Pros
- ✓Required labwork enforces baseline monitoring
- ✓Both semaglutide and tirzepatide available
- ✓Clinician supervision through intake and follow-up
Cons
- ✗Pricing higher than aggressive compounded competitors
- ✗3.0★ Trustpilot score lower than peers — review independent feedback before committing
Willow
Pros
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
Our Verdict
Willow edges out Ways2Well with a higher overall score of 7.2/10 and is particularly strong for mainstream telehealth GLP-1 access. Ways2Well remains a solid alternative, especially if you're looking for patients wanting required-labs structure rather than questionnaire-only intake.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.